文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克患者非复苏液体的方案化限制与常规治疗(REDUSE):一项随机多中心可行性试验

Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE): a randomized multicentre feasibility trial.
PubMed 文献 · Crit Care · 2024-05-17
一句话结论在6个瑞典ICU的脓毒性休克成人中,方案化限制非复苏液体使前3天总液体量较常规治疗减少约3560 ml,该设计用于检验能否改善结局是可行的。

该多中心随机可行性试验在6个瑞典ICU纳入脓毒性休克成人,于入ICU 12小时内随机分为方案化限制非复苏液体组(n=44)与常规治疗组(n=48)。主要终点为纳入后3天内总液体量,限制组中位6008 ml(IQR 3960-8123)vs 对照组9765 ml(IQR 6804-12401),Hodges-Lehmann中位差3560 ml(95%CI 1614-5302),p<0.001。全因死亡、无机械通气且无急性肾损伤或缺血事件的天数等结局数据记录完整(98/98、95/98、95/98),6个月认知与健康相关生活质量在存活者中记录39/52(75%)与41/52(79%)。134例合格患者中90例(67%)被随机,15/98(15%)至少发生一次方案违背。结论认为该设计用于检验减少非复苏液体能否改善结局是可行的。

要点

  • 脓毒性休克成人入ICU 12小时内随机,限制组前3天总液体量中位6008 ml(IQR 3960-8123),对照组9765 ml(IQR 6804-12401)。
  • 限制组较对照组总液体量中位差3560 ml(95%CI 1614-5302),p<0.001。
  • 全因死亡、无机械通气且无急性肾损伤或缺血事件天数记录完整率分别为98/98(100%)、95/98(98%)、95/98(98%)。
  • 6个月认知与健康相关生活质量在存活者中记录率分别为39/52(75%)与41/52(79%)。
  • 134例合格患者中90例(67%)被随机,15/98(15%)至少发生一次方案违背。

适用人群与场景

  • 6个瑞典ICU的脓毒性休克成人,于入ICU 12小时内随机。

处置流程与药物剂量

  • 方案化限制非复苏液体组接受针对非复苏液体的限制性方案,对照组接受常规治疗。

研究设计与关键结果

  • 多中心随机可行性试验,限制组n=44,对照组n=48;主要终点为纳入后3天内总液体量,限制组中位6008 ml(IQR 3960-8123)vs 对照组9765 ml(IQR 6804-12401),Hodges-Lehmann中位差3560 ml(95%CI 1614-5302),p<0.001。
  • 全因死亡、无机械通气且无急性肾损伤或缺血事件的天数(ICU内、纳入后90天内)记录于98/98(100%)、95/98(98%)和95/98(98%)的参与者。
  • 6个月认知与健康相关生活质量记录于存活者的39/52(75%)和41/52(79%)。
  • 134例合格患者中90例(67%)被随机,15/98(15%)的参与者至少发生一次方案违背。

证据类型、等级与局限

  • 多中心随机可行性试验;试验注册号NCT05249088,注册日期2022年2月18日。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在脓毒性休克患者中方案化限制非复苏液体较常规治疗大幅减少液体 administration;采用该设计检验减少非复苏液体能否改善结局是可行的。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND/PURPOSE: Non-resuscitation fluids constitute the majority of fluid administered for septic shock patients in the intensive care unit (ICU). This multicentre, randomized, feasibility trial was conducted to test the hypothesis that a restrictive protocol targeting non-resuscitation fluids reduces the overall volume administered compared with usual care.

METHODS: Adults with septic shock in six Swedish ICUs were randomized within 12 h of ICU admission to receive either protocolized reduction of non-resuscitation fluids or usual care. The primary outcome was the total volume of fluid administered within three days of inclusion.

RESULTS: Median (IQR) total volume of fluid in the first three days, was 6008 ml (interquartile range [IQR] 3960-8123) in the restrictive fluid group (n = 44), and 9765 ml (IQR 6804-12,401) in the control group (n = 48); corresponding to a Hodges-Lehmann median difference of 3560 ml [95% confidence interval 1614-5302]; p < 0.001). Outcome data on all-cause mortality, days alive and free of mechanical ventilation and acute kidney injury or ischemic events in the ICU within 90 days of inclusion were recorded in 98/98 (100%), 95/98 (98%) and 95/98 (98%) of participants respectively. Cognition and health-related quality of life at six months were recorded in 39/52 (75%) and 41/52 (79%) of surviving participants, respectively. Ninety out of 134 patients (67%) of eligible patients were randomized, and 15/98 (15%) of the participants experienced at least one protocol violation.

CONCLUSION: Protocolized reduction of non-resuscitation fluids in patients with septic shock resulted in a large decrease in fluid administration compared with usual care. A trial using this design to test if reducing non-resuscitation fluids improves outcomes is feasible.

TRIAL REGISTRATION: Clinicaltrials.gov, NCT05249088, 18 February 2022. https://clinicaltrials.gov/ct2/show/NCT05249088.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Lindén A, Spångfors M, Olsen MH, et al. Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE): a randomized multicentre feasibility trial. Crit Care. 2024. PMID: 38760833. doi:10.1186/s13054-024-04952-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。